| - Industry | - Sector | Mr. Ruijia Yang CEO | SSE Exchange | CNE100005PV8 ISIN |
| CN Country | 481 Employees | 26 May 2026 Last Dividend | - Last Split | - IPO Date |
Nanjing Medlander Medical Technology Co.,Ltd., established in 2013, is a significant player in the medical technology realm, focusing on the development and provision of advanced pelvic floor rehabilitation equipment alongside comprehensive clinical solutions within China. Operating from its base in Nanjing, China, the company serves a diverse range of healthcare sectors including gynecology, obstetrics, rehabilitation, anorectal, and urology, thereby addressing a wide spectrum of medical needs related to pelvic floor disorders. Through its dedicated research and development efforts, Nanjing Medlander Medical Technology Co.,Ltd. has positioned itself as a key provider of specialized medical equipment and solutions that aim to enhance the quality of life of patients dealing with pelvic floor issues.